Pattern of QTc prolongation in Methadone Maintenance Therapy (MMT) subjects receiving different methadone dosages: A prospective cohort study
- PMID: 24353706
- PMCID: PMC3858916
- DOI: 10.12669/pjms.295.3395
Pattern of QTc prolongation in Methadone Maintenance Therapy (MMT) subjects receiving different methadone dosages: A prospective cohort study
Abstract
Objectives: This study aimed to compare the QTc interval between low and high dose methadone groups and evaluate the pattern of QTc variation.
Methods: This is a prospective cohort study conducted from December 2010 till August 2011 at Malaysian University of Science's Hospital. Forty six subjects, grouped in high dose (>80mg) and low dose (<80mg) oral methadone, were followed-up at 4-weekly for QTc measurements. Relevant demographic and biochemical profiles were taken at intervals with concurrent QTc measurements.
Results: No significant QTc differences between methadone dosage groups were found at Week 0 (434ms vs 444ms, p = 0.166) and week 8 (446.5ms vs 459ms, p = 0.076), but not at week 4(435ms vs 450ms, p = 0.029). However, there were significant associations between the groups with QTc prolongation at week 0 and 4 (OR 4.29(95% CI 1.01, 18.72) p=0.044 and OR 5.18 (95% CI 1.34, 20.06) p =0.013, respectively) but not at week 8 (OR 2.44 (95% CI 0.74, 8.01) p=0.139). On multivariate analysis, dose group was the sole significant factor for QTc prolongation for week 0 and 4 (p values 0.047 and 0.017, respectively), but not at week 8.
Conclusion: High-dose methadone group is more likely to develop prolonged QTc than low-dose group. However, such effects were inconsistent and occurred even during chronic methadone therapy, mandating judicious QTc and serum methadone monitoring.
Keywords: High Dose; Low Dose; Methadone; QTc.
Figures
Similar articles
-
Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.Addiction. 2012 Jun;107(6):1132-9. doi: 10.1111/j.1360-0443.2011.03767.x. Epub 2012 Feb 28. Addiction. 2012. PMID: 22168435
-
Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.J Addict Med. 2013 Nov-Dec;7(6):428-34. doi: 10.1097/ADM.0b013e3182a8a4f2. J Addict Med. 2013. PMID: 24145160
-
Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.J Palliat Med. 2017 Jul;20(7):722-728. doi: 10.1089/jpm.2016.0411. Epub 2017 Feb 10. J Palliat Med. 2017. PMID: 28186837
-
Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.J Addict Dis. 2013;32(3):244-51. doi: 10.1080/10550887.2013.824333. J Addict Dis. 2013. PMID: 24074190
-
Evaluation of QTc Interval Prolongation Among Patients With Cancer Using Enteral Methadone.Am J Hosp Palliat Care. 2019 Mar;36(3):177-184. doi: 10.1177/1049909118811904. Epub 2018 Nov 14. Am J Hosp Palliat Care. 2019. PMID: 30428683
Cited by
-
A synonymous KCNH2 polymorphism and methadone trough level influence QTc prolongation in Kelantanese Malay recipients of methadone maintenance therapy (MMT) in Malaysia.PLoS One. 2025 May 5;20(5):e0322724. doi: 10.1371/journal.pone.0322724. eCollection 2025. PLoS One. 2025. PMID: 40323987 Free PMC article.
References
-
- Viswanath B, Chand P, Benegal V, Murthy P. Agonist treatment in opioid use: advances and controversy. Asian J Psychiatr. 2012;5(2):125–131. doi: http://dx. - PubMed
-
- Lobmann R, Verthein U. Explaining the effectiveness of heroin-assisted treatment on crime reductions. Law Hum Behav. 2009;33:89–95. doi: http://dx. - PubMed
-
- Portenoy RK. Pain 3: Treatment of cancer pain. Lancet. 2011;337(9784):2236–2247. doi: http://dx. - PubMed
LinkOut - more resources
Full Text Sources